BIOGRAPHY
Esther Freeman, MD, PhD, is the CeraVe/L'Oreal Endowed Chair of Global Health Dermatology at Massachusetts General Hospital, Harvard Medical School. She also serves as the Director of Clinical Innovation and Education for the Center for Global Health at Massachusetts General Hospital. As founding and immediate past chair of GLODERM (the International Alliance for Global Health Dermatology), she developed an international mentorship program for dermatology changemakers from under-resourced settings around the globe. She is the Vice Chair of the International Foundation for Dermatology, which is the foundation arm of the International League of Dermatologic Societies (ILDS). Her work as a physician-scientist and epidemiologist focuses on access to care and infectious diseases affecting underserved populations globally. She is the principal investigator of the American Academy of Dermatology and ILDS registry for COVID-19, Mpox, and Emerging Infections, and has won two Presidential Citations from the American Academy of Dermatology for her work. She has been a consultant to the World Health Organization. In addition to her >100 scientific papers, some of which have been viewed more than >1 million times in the New England Journal of Medicine, her work has been cited extensively in the lay press, including the New York Times, The Washington Post, and National Geographic.
SESSIONS
DISCLOSURES
American Academy of Dermatology – Advisory Board(No Compensation Received); British Journal of Dermatology – Other(Salary); CeraVe – Advisory Board(Honoraria); Harvard University – Speaker(Honoraria); International League of Dermatologic Societies – Investigator(Grants/Research Funding); L'Oreal – Advisory Board(Honoraria); National Institutes of Health – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Honoraria);